Larry Jasinski on VA policy
From Featured Guest: Larry Jasinski, CEO of ReWalk robotic exoskeletons · · Bonati Spine Institute
“One very important thing that just occurred about 10 days after the FDA cleared the rewalk product the veterans administration at the James J Peters VA and the Bronx put out an official policy statement from the medical director that they will pay for this for veterans that are successful in the program at the VA Bronx.”
On , Larry Jasinski, CEO at Lifeward, spoke about VA policy during Featured Guest: Larry Jasinski, CEO of ReWalk robotic exoskeletons on Bonati Spine Institute.
About Larry Jasinski
Larry Jasinski, CEO of Lifeward (formerly ReWalk), discussed the company's progress and financial outlook in a July 2025 interview at THE ISRAEL CONFERENCE. He stated that the company's revenue for the year would be between $28 million and $30 million, and that it would reach break-even at around $40 million in revenue. Jasinski noted that after five years of effort, the company's exoskeleton technology became covered by insurance in April of the previous year, and that the company is working to secure coverage from private insurers. In a 2014 interview, Jasinski said the ReWalk exoskeleton for home use was priced at $69,500. He stated that the company was providing data to insurance companies on cost savings to the healthcare system and working with various groups to obtain reimbursement. Jasinski also noted that the Veterans Administration's James J. Peters VA Medical Center in the Bronx had issued a policy statement agreeing to pay for the device for eligible veterans.